Since 2023, Indianapolis-based Lilly has filed lawsuits against dozens of compound pharmacies, weight-loss centers and health spas that produced and sold copies of its Type 2 diabetes treatment Mounjaro and weight-loss treatment Zepbound
It has also been demonstrated that inhibitory GABAergic CNS GIPR + neurons are necessary for the food intake reducing effects of GIPR agonists and dual incretin co-agonists (54, 55), while excitatory glutamatergic CNS GLP-1R + neurons are necessary for the food intake reducing effects of GLP-1R agonists (71)
Once the peer reviewed paper is out and published and people have a chance to fully digest all the findings, it should be reassuring to physicians regarding the possibility of using a medication like this with patients that they're treating who already have cardiovascular disease to help them avoid even more serious consequences down the road. This isnt the first time Wegovy has made news
The drug works by mimicking hormones that regulate blood sugar levels and slow gastric emptying
When comparing Qsymia vs Wegovy or Qsymia vs Zepbound, newer medications like the GLP-1s represent a leap forward in weight management